Grants and Contributions:
Agreement Number:
-
Agreement Value:
$105,000.00
Agreement Date:
Sep 1, 2018 - Aug 31, 2021
Description:
A genetic analysis of the pharmacokinetic and pharmacodynamic pathways of cetuximab; to assess efficacy and toxicity outcomes in chemotherapy-refractory, metastatic colorectal cancer patients from the Canadian Cancer Trials Group CO.20 and CO.17 trials.
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 2C4
Reference Number:
236-2018-2019-Q2-00342
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient's Legal Name:
Latifovic, Lidija
Research Organization:
University Health Network (Toronto)